Core Scientific (CORZ) Net Income towards Common Stockholders (2020 - 2026)

Core Scientific has reported Net Income towards Common Stockholders for 7 years, with the latest figure at -$1.2 billion in Q2 2026.

• Quarterly Net Income towards Common Stockholders fell 23.33% year-over-year to -$1.2 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$1.4 billion (down 29.23% YoY) and the FY2025 annual result came in at -$288.6 million, up 79.93% from the prior year.
• Net Income towards Common Stockholders retreated to -$1.2 billion in Q2 2026 per CORZ's latest filing, from -$347.2 million in the prior quarter.
• Over five years, Net Income towards Common Stockholders peaked at $576.3 million in Q1 2025 and troughed at -$1.2 billion in Q2 2026.
• A 5-year average of -$312.3 million and a median of -$319.2 million in 2024 frame the typical range for Net Income towards Common Stockholders.
• The sharpest annual moves came in 2022 and 2024: Net Income towards Common Stockholders slumped 23638.28% in 2022, then jumped 54401.8% in 2024.
• Over 5 years, Net Income towards Common Stockholders stood at -$434.8 million in 2022, then surged by 54.99% to -$195.7 million in 2023, then slumped by 48.78% to -$291.2 million in 2024, then soared by 174.17% to $216.0 million in 2025, then tumbled by 634.98% to -$1.2 billion in 2026.
• According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$1.2 billion, -$347.2 million, and $216.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.